Hypoxia and complement-and-coagulation pathways in the deceased organ donor as the major target for intervention to improve renal allograft outcome

Transplantation

Volumn 99, Issue 6, 2015, Pages 1293-1300

  Damman, Jeffrey ^a   Bloks, Vincent W ^b   Daha, Mohamed R ^b,c   J Van Der Most, Peter ^b   Sanjabi, Bahram ^b   Van Der Vlies, Pieter ^b   Snieder, Harold ^b   Ploeg, Rutger J ^d   Krikke, Christina ^b   Leuvenink, Henri G D ^b   Seelen, Marc A ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; TRANSCRIPTOME;

ARTICLE; BLOOD CLOTTING; BRAIN DEATH; CADAVER DONOR; CLINICAL EFFECTIVENESS; COLD ISCHEMIA; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENETIC ASSOCIATION; GLUCONEOGENESIS; GLYCOLYSIS; GRAFT FAILURE; GRAFT SURVIVAL; HEART DEATH; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY ISCHEMIA; LIVING DONOR; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REGULATORY MECHANISM; REPERFUSION INJURY; TRANSCRIPTOMICS; URINALYSIS; ALLOGRAFT; ANOXIA; COHORT ANALYSIS; COMPLEMENT ACTIVATION; DELAYED GRAFT FUNCTION; DONOR; IMMUNOLOGY; KIDNEY TRANSPLANTATION; PHYSIOLOGY; REPERFUSION; TRANSPLANTATION; TREATMENT OUTCOME; URINE;

ALLOGRAFTS; ANOXIA; BLOOD COAGULATION; COHORT STUDIES; COLD ISCHEMIA; COMPLEMENT ACTIVATION; DELAYED GRAFT FUNCTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALONDIALDEHYDE; REPERFUSION; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 84930537092     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000500     Document Type: Article

References (37)

1. Legendre C, Canaud G, Martinez F. Factors influencing long-term outcome after kidney transplantation. Transpl Int. 2014;27:19.
2. Opelz G, Döhler B. Multicenter analysis of kidney preservation. Transplantation. 2007;83:247.
3. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360:7.
4. NijboerWN, Moers C, Leuvenink HG, et al. How important is the duration of the brain death period for the outcome in kidney transplantation? Transpl Int. 2011;24:14.
5. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333:333.
6. Le Dinh H, Weekers L, Bonvoisin C, et al. Delayed graft function does not harm the future of donation-After-cardiac death in kidney transplantation. Transplant Proc. 2012;44:2795.
7. NaesensM, SarwalMM. Molecular diagnostics in transplantation. Nat Rev Nephrol. 2010;6:614.
8. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant. 2006;6:2903.
9. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation. 2000;69:405.
10. Hoeger S, Petrov K, Reisenbuechler A, et al. The additional detrimental effects of cold preservation on transplantation-Associated injury in kidneys from living and brain-dead donor rats. Transplantation. 2009;87:52.
11. Saat TC, Susa D, Roest HP, et al. A comparison of inflammatory, cytoprotective and injury gene expression profiles in kidneys from brain death and cardiac death donors. Transplantation. 2014;98:15.
12. Naesens M, Li L, Ying L, et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol. 2009;20:1839.
13. Kusaka M, Kuroyanagi Y, Mori T, et al. Global expression profiles in 1-hour biopsy specimens of human kidney transplantation from donors after cardiac death. Cell Transplant. 2009;18:647.
14. Cravedi P, Maggiore U, Mannon RB. Low-density array PCR analysis of reperfusion biopsies: An adjunct to histological analysis. Nephrol Dial Transplant. 2010;25:4077.
15. Hauser P, Schwarz C, Mitterbauer C, et al. Genome-wide geneexpression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest. 2004;84:353.
16. Mueller TF, Reeve J, Jhangri GS, et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant. 2008;8:78.
17. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol. 2005;16:1542.
18. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399.
19. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656.
20. van Dullemen LF, Bos EM, Schuurs TA, et al. Brain death induces renal expression of heme oxygenase-1 and heat shock protein 70. J Transl Med. 2013;11:22.
21. Kotsch K, Francuski M, Pascher A, et al. Improved long-termgraft survival after HO-1 induction in brain-dead donors. Am J Transplant. 2006;6:477.
22. Akhtar MZ, Sutherland AI, Huang H, et al. The role of hypoxia-inducible factors in organ donation and transplantation: the current perspective and future opportunities. Am J Transplant. 2014;14:1481.
23. Damman J, Nijboer WN, Schuurs TA, et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant. 2011;26:2345.
24. Damman J, Hoeger S, Boneschansker L, et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol. 2011;24:233.
25. Davis AE III, Mejia P, Lu F. Biological activities of C1 inhibitor. Mol Immunol. 2008;45:4057.
26. Castellano G, Melchiorre R, Loverre A, et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia reperfusion-induced renal damage. Am J Pathol. 2010;176:1648.
27. de Vries B, Matthijsen RA, Wolfs TG, et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation. 2003;75:375.
28. Arumugam TV, Shiels IA, Strachan AJ, et al. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int. 2003;63:134.
29. Huang Y, Shan J, Wang C, et al. Can ischemic preconditioning alone really protect organs from ischemia reperfusion injury in transplantation. Transpl Immunol. 2009;20:127.
30. Torras J, Herrero-Fresneda I, Lloberas N, et al. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 2002;61:2218.
31. Chen Y, Zheng H, Wang X, et al. Remote ischemic preconditioning fails to improve early renal function of patients undergoing living-donor renal transplantation: A randomized controlled trial. Transplantation. 2013;95:e4.
32. Wever KE, et al. Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine. Nephrol Dial Transplant. 2011;26:3108.
33. Lazaris AM, Maheras AN, Vasdekis SN, et al. Protective effect of remote ischemic preconditioning in renal ischemia/reperfusion injury, in a model of thoracoabdominal aorta approach. J Surg Res. 2009;154:267.
34. Murray E, Jenning RB, Reimer KA. Preconditioning with ischemia: A delay in lethal cell injury in ischemic myocardium. Circulation. 1986;74:1123.
35. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545.
36. Doniger SW, Salomonis N, Dahlquist KD, et al. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003;4:R7.
37. Goeman JJ, van de Geer SA, de Kort F, et al. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics. 2004;20:93.